|
 |
|
|||||||
|
|||||||||
© 2002 by the American Diabetes Association, Inc.
A Unique Defect in the Regulation of Visceral Fat Cell Lipolysis in the Polycystic Ovary Syndrome as an Early Link to Insulin Resistance
1 Department of Gynecology, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden
2 Department of Medicine, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden
3 Department of Cell and Molecular Biology, Lund University, Lund, Sweden
4 Department of Surgery, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden
The etiology of polycystic ovary syndrome (PCOS) is unknown. However, PCOS has a strong resemblance to the insulin resistance (metabolic) syndrome, where an increased rate of visceral fat cell lipolysis is believed to play a pathophysiological role. We hypothesized that primary defects in visceral lipolysis might also exist in PCOS. Ten young, nonobese, and otherwise healthy PCOS women were compared with 13 matched control women. In vitro lipolysis regulation and stoichiometric properties of the final step in lipolysis activation, namely the protein kinase A (PKA)-hormone sensitive lipase (HSL) complex, were investigated in isolated visceral (i.e., omental) fat cells. Body fat distribution and circulating levels of insulin, glucose, and lipids were normal in PCOS women. However, in vivo insulin sensitivity was slightly decreased (P = 0.03). Catecholamine-induced adipocyte lipolysis was markedly (i.e., about twofold) increased in PCOS women due to changes at the postreceptor level, although there was no change in the antilipolytic properties of visceral fat cells. Western blot analyses of visceral adipose tissue showed twofold increased levels of the catalytic and the regulatory I
components of PKA. In contrast, the regulatory RIIß component of PKA was almost 50% decreased in visceral adipose tissue in PCOS women. Recent studies on genetically modified mice have shown that a similar transition in the regulatory PKA units induces an increased lipolytic response to catecholamines. Further analysis showed that the level of HSL-short, an enzymatically inactive splice form of HSL, was decreased in PCOS (P < 0.01). The altered lipolysis in PCOS is different from that observed in visceral fat cells in the insulin resistance syndrome that occurs at the level of adrenergic receptors. We concluded that increased catecholamine-induced lipolysis in visceral fat cells may be due to unique alterations in the stoichiometric properties of the adipose PKA-HSL holoenzymes. This could be an early and possibly primary lipolysis defect in PCOS.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Ryden, J. Jocken, V. van Harmelen, A. Dicker, J. Hoffstedt, M. Wiren, L. Blomqvist, A. Mairal, D. Langin, E. Blaak, et al. Comparative studies of the role of hormone-sensitive lipase and adipose triglyceride lipase in human fat cell lipolysis Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1847 - E1855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Corton, J. I. Botella-Carretero, A. Benguria, G. Villuendas, A. Zaballos, J. L. San Millan, H. F. Escobar-Morreale, and B. Peral Differential Gene Expression Profile in Omental Adipose Tissue in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 328 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Lystedt, H. Westergren, J. Brynhildsen, L. Lindh-Astrand, J. Gustavsson, F. H Nystrom, M. Hammar, and P. Stralfors Subcutaneous adipocytes from obese hyperinsulinemic women with polycystic ovary syndrome exhibit normal insulin sensitivity but reduced maximal insulin responsiveness Eur. J. Endocrinol., December 1, 2005; 153(6): 831 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Hoffstedt, M. Ryden, H. Wahrenberg, V. van Harmelen, and P. Arner Upstream Transcription Factor-1 Gene Polymorphism Is Associated with Increased Adipocyte Lipolysis J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5356 - 5360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. B. Hammar, J.-C. Irminger, K. Rickenbach, G. Parnaud, P. Ribaux, D. Bosco, D. G. Rouiller, and P. A. Halban Activation of NF-{kappa}B by Extracellular Matrix Is Involved in Spreading and Glucose-stimulated Insulin Secretion of Pancreatic Beta Cells J. Biol. Chem., August 26, 2005; 280(34): 30630 - 30637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Corbould, Y.-B. Kim, J. F. Youngren, C. Pender, B. B. Kahn, A. Lee, and A. Dunaif Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E1047 - E1054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Faulds, M. Ryden, I. Ek, H. Wahrenberg, and P. Arner Mechanisms behind Lipolytic Catecholamine Resistance of Subcutaneous Fat Cells in the Polycystic Ovarian Syndrome J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2269 - 2273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Hagstrom-Toft, V. Qvisth, I. Nennesmo, M. Ryden, H. Bolinder, S. Enoksson, J. Bolinder, and P. Arner Marked Heterogeneity of Human Skeletal Muscle Lipolysis at Rest Diabetes, December 1, 2002; 51(12): 3376 - 3383. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Azziz Polycystic Ovary Syndrome, Insulin Resistance, and Molecular Defects of Insulin Signaling J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4085 - 4087. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Vrbikova, B. Bendlova, M. Hill, M. Vankova, K. Vondra, and L. Starka Insulin Sensitivity and {beta}-Cell Function in Women With Polycystic Ovary Syndrome Diabetes Care, July 1, 2002; 25(7): 1217 - 1222. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |